+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enterprise Imaging IT Market: Global Forecast to 2031- Product Image
Enterprise Imaging IT Market: Global Forecast to 2031- Product Image
New

Enterprise Imaging IT Market: Global Forecast to 2031

  • PDF Icon

    Report

  • 421 Pages
  • October 2026
  • Region: Global
  • Markets and Markets
  • ID: 6164735
MORE REGIONS AVAILABLE
Description Jump to:
The global enterprise imaging IT market is projected to reach USD 4.59 billion by 2031, up from USD 2.58 billion in 2026, at a CAGR of 12.2% from 2026 to 2031. Growth in the enterprise imaging IT market is driven by rising diagnostic imaging volumes, the increasing complexity of imaging data, and the need to improve the accessibility, management, and security of medical images across healthcare networks. More than 3.6 billion diagnostic radiology examinations are performed worldwide annually, generating large and continuously expanding volumes of imaging data that require scalable storage, interoperability, and enterprise-wide access. The scale of imaging repositories is further illustrated by Scotland’s national medical imaging archive, which contains approximately 2.47 billion DICOM images across 57.3 million studies, highlighting the growing data-management requirements of healthcare systems. Imaging activity is also increasing in the US, where FDA data indicate that more than 45 million mammography procedures were reported annually as of September 2026, across 9,128 certified facilities and 27,793 accredited units. These trends are increasing demand for enterprise imaging platforms, vendor-neutral archives, cloud-based storage, and interoperable image exchange solutions. However, adoption remains constrained by cybersecurity and integration challenges, as demonstrated by an HHS investigation involving a radiology provider whose PACS server breach exposed medical images of 21,778 individuals.

In 2025, on-premises deployment constituted the largest segment in the enterprise imaging IT market, by deployment mode

By deployment mode, on-premise solutions represented the largest share of the enterprise imaging IT market in 2025. Their leadership stems from hospitals and large healthcare organizations' continued preference for greater control over sensitive medical imaging data, IT infrastructure, security, and system performance. On-premises enterprise imaging platforms enable healthcare providers to keep imaging data within their own infrastructure while integrating with existing PACS, RIS, EHR, and clinical systems. The need to comply with data privacy and healthcare regulations, particularly for organizations with stringent data residency and security requirements, further supports adoption. Moreover, established investments in legacy imaging infrastructure and the high costs and complexity of migrating large imaging archives to the cloud are encouraging healthcare organizations to continue using on-premises solutions. However, increasing demand for scalability, remote image access, reduced infrastructure maintenance, and AI-enabled imaging workflows is expected to support a gradual shift toward cloud-based deployment during the forecast period.

The oncology segment by therapeutic area is expected to register the fastest growth during the forecast period

By therapeutic area, oncology is expected to be the fastest-growing segment of the enterprise imaging IT market, driven by the growing use of medical imaging for cancer screening, diagnosis, staging, treatment planning, and monitoring. The rising prevalence of cancer and demand for advanced imaging modalities, including CT, MRI, PET, and molecular imaging, are generating substantial volumes of oncology-related imaging data. Enterprise imaging platforms enable healthcare organizations to centrally store, access, share, and analyze these images across multidisciplinary oncology teams and care settings. Furthermore, the growing adoption of AI-enabled imaging for tumor detection, lesion characterization, treatment response assessment, and workflow prioritization is supporting demand for integrated imaging solutions. The expansion of precision oncology and multidisciplinary cancer care is further increasing the need for interoperable platforms that connect imaging data with EHRs, oncology information systems, and other clinical applications.

Asia Pacific to witness the highest growth rate during the forecast period

The Asia Pacific region is projected to post the highest growth rate in the enterprise imaging IT market over the forecast period, supported by rapid healthcare digitalization, expanding diagnostic imaging infrastructure, and growing adoption of cloud-based and AI-enabled imaging solutions. China is accelerating the development of regional medical imaging infrastructure, with the National Health Commission reporting that medical imaging centers now cover more than 70% of township health centers, enabling greater sharing of diagnostic resources between primary and higher-level facilities. In August 2025, China's National Healthcare Security Administration reported that 22 provinces had deployed software for a national medical imaging cloud-sharing pathway, with 17 provinces enabling cross-provincial access to imaging data and more than 18.48 million imaging index records aggregated nationally. India is also expanding its digital healthcare infrastructure; as of July 2026, more than 948.7 million ABHA accounts and 536,000 healthcare facilities had been registered under the Ayushman Bharat Digital Mission, strengthening the digital ecosystem required for interoperable healthcare data exchange. Furthermore, China is promoting AI-enabled medical imaging, including intelligent image-assisted diagnosis and report generation, while Japan and other technologically advanced Asia Pacific markets continue to strengthen enterprise imaging and PACS infrastructure. These developments, alongside rising imaging volumes, expanding multi-site healthcare networks, growing teleradiology adoption, and demand for interoperable image-sharing platforms, are expected to accelerate adoption of enterprise imaging IT solutions across Asia Pacific.

The breakdown of primary participants is as mentioned below:

  • By Company Type - Tier 1: 34%, Tier 2: 46%, and Tier 3: 20%
  • By Designation - C-level: 35%, Director-level: 25%, and Others: 40%
  • By Region - North America: 30%, Europe: 45%, Asia Pacific: 20%, Middle East & Africa: 3%, Latin America: 2%

Key Players in the Enterprise Imaging IT Market

The key players functioning in the enterprise imaging IT market include Agfa-Gevaert Group. (Belgium), FUJIFILM Corporation (Japan), Merative (US), Pro Medicus, Ltd. (Australia), Optum, Inc. (US), GE HealthCare (US), Sectra AB (Sweden), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hyland Software, Inc. (US), Koninklijke Philips N.V. (Netherlands), among others.

Research Coverage:

The scope of the report covers detailed information on the major factors, such as drivers, restraints, challenges, and opportunities, that influence the growth of the enterprise imaging IT market. A detailed analysis of key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; contracts, partnerships, and agreements; new product and service launches; mergers and acquisitions; and recent developments associated with the enterprise imaging IT market. The report also covers a competitive analysis of upcoming startups in the enterprise imaging IT market ecosystem.

Reasons to Buy the Report

This report will help established firms and new or smaller entrants gauge the market's pulse, which, in turn, would help them gain a greater share of the market. Firms purchasing the report could use one or more of the strategies mentioned below to strengthen their positions in the market.

This report provides insights on:

 Analysis of key drivers (growing volume of medical imaging procedures, increasing demand for scalable and cost-effective solutions, increasing adoption of cloud-based enterprise imaging solutions), restraints (data security and privacy concerns, lack of skilled professionals for deployment and interpretation), opportunities (growth of vendor-neutral archives (VNA) and interoperability, increasing adoption of AI-enabled imaging and advanced visualization), and challenges (limited adoption in developing regions, high upfront integration and deployment costs) influencing the growth of the enterprise imaging IT market.
 Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and new product launches in the enterprise imaging IT market.
 Market Development: Comprehensive information on the lucrative emerging markets, function, modality, application, offering, deployment mode, therapeutic area, end-users, and regions.
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the enterprise imaging IT market.
 Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the enterprise imaging IT market such as Agfa-Gevaert Group. (Belgium), FUJIFILM Corporation (Japan), Merative (US), Pro Medicus, Ltd. (Australia), Optum, Inc. (US), GE HealthCare (US), Sectra AB (Sweden), CANON MEDICAL SYSTEMS CORPORATION (Japan), Hyland Software, Inc. (US), Koninklijke Philips N.V. (Netherlands), among others.

Table of Contents

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.4 YEARS CONSIDERED
1.5 CURRENCY
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 ENTERPRISE IMAGING IT MARKET OVERVIEW
3.2 ENTERPRISE IMAGING IT MARKET, BY APPLICATION & REGION
3.3 ENTERPRISE IMAGING IT MARKET: GEOGRAPHIC SNAPSHOT
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increased demand for scalable and cost-effective solutions
4.2.1.2 Advancements in AI and imaging technologies
4.2.1.3 Growing volume of medical imaging procedures
4.2.1.4 Growing need for remote access and collaborative care
4.2.1.5 Government initiatives and favorable policies
4.2.2 RESTRAINTS
4.2.2.1 Data security and privacy concerns
4.2.2.2 Lack of skilled professionals for deployment and interpretation
4.2.3 OPPORTUNITIES
4.2.3.1 Expansion into emerging markets
4.2.3.2 Multi modality and advanced visualization
4.2.3.3 Partnerships with AI and analytics providers
4.2.3.4 Value-based care and population health management
4.2.3.5 Cloud native and edge computing innovations
4.2.4 CHALLENGES
4.2.4.1 Interoperability with legacy and vendor-specific systems
4.2.4.2 High upfront integration and deployment costs
4.2.4.3 Workflow disruption and user adoption
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 BARGAINING POWER OF SUPPLIERS
5.1.2 BARGAINING POWER OF BUYERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 THREAT OF NEW ENTRANTS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT MARKET,BY OFFERING (2025)
5.5.2 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT SOLUTIONS,BY REGION (2025)
5.6 KEY CONFERENCES AND EVENTS, 2026-2027
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 CASE STUDY ANALYSIS
5.10 IMPACT OF 2025 US TARIFFS ON ENTERPRISE IMAGING IT MARKET
5.10.1 INTRODUCTION
5.10.2 KEY TARIFF RATES
5.10.3 PRICE IMPACT ANALYSIS
5.10.3.1 Increased costs of hardware components
5.10.3.2 Software & licensing inflation
5.10.3.3 Supply chain disruption
5.10.4 IMPACT ON COUNTRY/REGION
5.10.4.1 US
5.10.4.2 Europe
5.10.4.3 Asia Pacific
5.10.5 IMPACT ON END USERS
5.10.5.1 Hospitals (large, mid-sized, and academic medical centers)
5.10.5.2 Diagnostic centers (independent and chain-based)
5.10.5.3 Teleradiology providers
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY EMERGING TECHNOLOGIES
6.1.1 IMAGING ANALYTICS PLATFORMS
6.1.2 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
6.1.3 MULTI MODALITY FUSION & CO REGISTRATION ENGINES
6.1.4 ZERO FOOTPRINT VIEWERS
6.1.5 MOBILE ENTERPRISE IMAGING AND WORKFLOW BOTS
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 RADIOLOGY INFORMATION SYSTEMS (RIS)
6.2.2 ELECTRONIC HEALTH RECORD (EHR/EMR) INTEGRATION
6.3 ADJACENT TECHNOLOGIES
6.3.1 CLOUD COMPUTING & STORAGE
6.3.2 BLOCKCHAIN & DISTRIBUTED LEDGER TECHNOLOGY
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.5 PATENT ANALYSIS
6.5.1 PATENT PUBLICATION TRENDS FOR ENTERPRISE IMAGING IT MARKET
6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
6.6.1 AI-DRIVEN IMAGE ANALYSIS & CLINICAL DECISION SUPPORT
6.6.2 CLOUD-BASED IMAGING & ENTERPRISE-WIDE DATA MANAGEMENT
6.6.3 MULTIDISCIPLINARY IMAGING & INTEROPERABLE CLINICAL WORKFLOWS
6.6.4 ADVANCED VISUALIZATION, DIGITAL PATHOLOGY, AND PRECISION HEALTHCARE
6.6.5 AUTOMATED IMAGING WORKFLOWS & INTELLIGENT DATA GOVERNANCE
6.7 IMPACT OF GENERATIVE AI ON ENTERPRISE IMAGING IT MARKET
6.7.1 INTRODUCTION
6.7.2 TOP USE CASES & MARKET POTENTIAL
6.7.2.1 Key use cases
6.7.3 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
6.7.3.1 Case Study 1: Enabling interoperability and scalability across enterprise imaging networks with Dicom Systems’ Unifier Platform
6.7.3.2 Case Study 2: San Gerardo Hospital transforms radiology with Agfa HealthCare’s Enterprise Imaging
6.7.4 INTERCONNECTED & ADJACENT MARKETS
6.7.4.1 Vendor-neutral Archive (VNA) & PACS market
6.7.4.2 Medical image analysis software market
6.7.4.3 Healthcare IT market
6.7.5 USER READINESS & IMPACT ASSESSMENT
6.7.5.1 User readiness
6.7.5.1.1 User A: Hospitals
6.7.5.1.2 User B: Diagnostic centers
6.7.5.2 Impact assessment
6.7.5.2.1 User A: Hospitals
6.7.5.2.1.1 Implementation
6.7.5.2.1.2 Impact
6.7.5.2.2 User B: Diagnostic centers
6.7.5.2.2.1 Implementation
6.7.5.2.2.2 Impact
7 REGULATORY LANDSCAPE
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
7.1.2 REGULATORY FRAMEWORK
7.1.2.1 North America
7.1.2.2 Europe
7.1.2.3 Asia Pacific
7.1.2.4 Latin America
7.1.2.5 Middle East & Africa
7.1.3 INDUSTRY STANDARDS
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1 INTRODUCTION
8.2 DECISION-MAKING PROCESS
8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.3.2 BUYING CRITERIA
8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.5 UNMET NEEDS FROM VARIOUS END USERS
8.5.1 UNMET NEEDS
8.5.2 END USER EXPECTATIONS
8.6 MARKET PROFITABILITY
9 ENTERPRISE IMAGING IT MARKET, BY FUNCTION
9.1 INTRODUCTION
9.2 VENDOR-NEUTRAL ARCHIVES (VNA)
9.2.1 ADVANCING SEAMLESS INFORMATION EXCHANGE THROUGH VNA SOLUTIONS TO BOOST MARKET GROWTH
9.3 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS)
9.3.1 GROWING INTEGRATION OF AI WITHIN PACS FOR OPTIMIZED RADIOLOGY WORKFLOWS TO SUPPORT MARKET GROWTH
9.4 IMAGE EXCHANGE
9.4.1 GROWING POPULARITY OF INTEROPERABLE IMAGING NETWORKS FOR PATIENT-CENTERED DATA SHARING TO DRIVE GROWTH
9.5 UNIVERSAL VIEWERS
9.5.1 GROWING UNIVERSAL VIEWER DEPLOYMENT FOR MULTI-DISCIPLINARY IMAGING TO FUEL MARKET
9.6 WORKFLOW ORCHESTRATION
9.6.1 AI-POWERED IMAGING WORKFLOW AUTOMATION AND CROSS-MODALITY COORDINATION TO PROPEL MARKET
9.7 ANALYTICS
9.7.1 GROWING NEED FOR ANALYTICS PLATFORMS FOR VALUE-BASED IMAGING AND OPERATIONAL OPTIMIZATION TO DRIVE MARKET
9.8 OTHER FUNCTIONS
10 ENTERPRISE IMAGING IT MARKET, BY MODALITY
10.1 INTRODUCTION
10.2 X-RAY
10.2.1 GROWTH IN ENTERPRISE IMAGING THROUGH AI-ENABLED X-RAY SOLUTIONS TO BOOST MARKET
10.3 MAGNETIC RESONANCE IMAGING (MRI)
10.3.1 EXPANDING MRI ENTERPRISE IT TO MEET RISING NEUROLOGICAL IMAGING DEMANDS TO SUPPORT MARKET GROWTH
10.4 COMPUTED TOMOGRAPHY (CT)
10.4.1 REGULATORY AND VALUE-BASED INCENTIVES TO FUEL CT IMAGING IT ADOPTION
10.5 ULTRASOUND
10.5.1 AI-POWERED ULTRASOUND AND POCUS TO ACCELERATE ENTERPRISE IMAGING TRANSFORMATION
10.6 NUCLEAR IMAGING
10.6.1 POSITRON EMISSION TOMOGRAPHY (PET)
10.6.1.1 Rising PET scan volumes to drive demand for scalable, intelligent Imaging IT
10.6.2 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT)
10.6.2.1 Driving diagnostic accuracy with automated SPECT workflows to contribute to growth
10.7 ENDOSCOPY
10.7.1 ENABLING REAL-TIME ENDOSCOPIC INSIGHTS THROUGH CLOUD-NATIVE VIDEO ORCHESTRATION TO DRIVE MARKET
10.8 MAMMOGRAPHY
10.8.1 NEED FOR ENTERPRISE IMAGING SOLUTIONS FOR HIGH-VOLUME, HIGH-RESOLUTION MAMMOGRAPHY WORKFLOWS TO FUEL GROWTH
10.9 FLUOROSCOPY
10.9.1 STRATEGIC CLOUD-NATIVE IMAGING FOR ADVANCED FLUOROSCOPY USE CASES TO AID WITH GROWTH
10.10 ECHOCARDIOGRAPHY
10.10.1 ABILITY TO ENHANCE FLUOROSCOPY IMAGING EFFICIENCY WITH AI-INTEGRATED ENTERPRISE IT SOLUTIONS TO BOOST MARKET
10.11 OTHER MODALITIES
11 ENTERPRISE IMAGING IT MARKET, BY APPLICATION
11.1 INTRODUCTION
11.2 DIAGNOSTICS
11.2.1 AI-ENABLED QUANTIFICATION AND INTEGRATED THERANOSTIC WORKFLOWS TO DRIVE DIAGNOSTIC IMAGING TRANSFORMATION
11.3 THERAPEUTICS
11.3.1 ADVANTAGES SUCH AS MULTIMODAL TREATMENT INTEGRATION TO OPTIMIZE ENTERPRISE IMAGING FOR THERAPEUTIC WORKFLOWS
11.4 CLINICAL RESEARCH
11.4.1 AI-ENABLED QUANTIFICATION AND RAPID-RESPONSE IMAGING WORKFLOWS TO ACCELERATE CLINICAL RESEARCH
12 ENTERPRISE IMAGING IT MARKET, BY OFFERING
12.1 INTRODUCTION
12.2 SOFTWARE
12.2.1 ADVANCING UNIFIED IMAGING ECOSYSTEMS THROUGH CLOUD-NATIVE SOFTWARE TO BOOST MARKET GROWTH
12.3 SERVICES
12.3.1 ADVANTAGES SUCH AS EXPERT SERVICES, CLOUD MIGRATION, AND WORKFLOW OPTIMIZATION TO SUPPORT MARKET GROWTH
13 ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE
13.1 INTRODUCTION
13.2 ON-PREMISE SOLUTIONS
13.2.1 GROWING NEED FOR IMAGING PERFORMANCE AND DATA CONTROL THROUGH ON-PREMISE DEPLOYMENT TO SUPPORT MARKET GROWTH
13.3 CLOUD-BASED SOLUTIONS
13.3.1 RISING NEED FOR COST-EFFICIENT, SCALABLE INFRASTRUCTURE TO DRIVE DEMAND FOR CLOUD-BASED DEPLOYMENT
13.4 HYBRID SOLUTIONS
13.4.1 ABILITY TO BRIDGE DATA CONTROL AND CLOUD INNOVATION THROUGH HYBRID DEPLOYMENT TO BOOST GROWTH
14 ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA
14.1 INTRODUCTION
14.2 NEUROLOGY
14.2.1 INTEGRATION OF AI-DRIVEN MULTIMODAL NEUROIMAGING FOR PERSONALIZED NEUROLOGICAL CARE TO BOOST MARKET
14.3 CARDIOLOGY
14.3.1 CLOUD-ENABLED, AI-DRIVEN ENTERPRISE IMAGING PLATFORMS TO ACCELERATE ADVANCED CARDIAC DIAGNOSTICS
14.4 ONCOLOGY
14.4.1 AI-DRIVEN, MULTIMODAL ENTERPRISE IMAGING PLATFORMS TO ADVANCE PRECISION ONCOLOGY
14.5 ORTHOPEDICS
14.5.1 ABILITY OF AI-ENABLED ENTERPRISE IMAGING PLATFORMS TO TRANSFORM ORTHOPEDIC CARE TO DRIVE DEMAND
14.6 OTHER THERAPEUTIC AREAS
15 ENTERPRISE IMAGING IT MARKET, BY END USER
15.1 INTRODUCTION
15.2 HOSPITALS
15.2.1 HOSPITALS TO DRIVE DEMAND FOR UNIFIED IMAGING INFRASTRUCTURE TO SUPPORT INTEGRATED CARE DELIVERY
15.3 DIAGNOSTIC CENTERS
15.3.1 GROWING ADOPTION OF ENTERPRISE IMAGING IT TO ENHANCE WORKFLOW EFFICIENCY IN DIAGNOSTIC CENTERS TO BOOST MARKET
15.4 CLINICS & OUTPATIENT SETTINGS
15.4.1 GROWING POPULARITY OF LIGHTWEIGHT ENTERPRISE IMAGING IT TO BOOST EFFICIENCY AND PATIENT THROUGHPUT TO FUEL GROWTH
15.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
15.5.1 GROWING USE OF ENTERPRISE IMAGING IT FOR TRANSLATIONAL RESEARCH AND DRUG DEVELOPMENT TO DRIVE MARKET
15.6 MEDTECH COMPANIES
15.6.1 ABILITY OF ENTERPRISE IMAGING IT TO ACCELERATE DEVICE INNOVATION AND CLINICAL INTEGRATION TO FUEL ADOPTION
15.7 RESEARCH & ACADEMIC INSTITUTES
15.7.1 GROWING NEED TO POWER DATA-DRIVEN DISCOVERY AND COLLABORATION TO SUPPORT MARKET GROWTH
15.8 OTHER END USERS
16 ENTERPRISE IMAGING IT MARKET, BY REGION
16.1 INTRODUCTION
16.2 NORTH AMERICA
16.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
16.2.2 US
16.2.2.1 AI integration, cloud adoption, and regulatory push to accelerate enterprise imaging IT transformation in US
16.2.3 CANADA
16.2.3.1 Provincial interoperability mandates and cloud-enabled AI to drive growth in Canada's imaging IT market
16.3 EUROPE
16.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
16.3.2 GERMANY
16.3.2.1 Hospital modernization and ePA adoption to propel Germany’s enterprise imaging IT growth
16.3.3 UK
16.3.3.1 NHS push for AI-driven imaging and cloud integration to fuel market growth
16.3.4 FRANCE
16.3.4.1 Accelerated cloud-native, interoperable imaging platforms with focus on data sovereignty to drive market
16.3.5 ITALY
16.3.5.1 Growing VNA and teleradiology adoption in Italy to modernize imaging infrastructure
16.3.6 SPAIN
16.3.6.1 Spain to scale cloud imaging and VNA for regional collaboration
16.3.7 REST OF EUROPE
16.4 ASIA PACIFIC
16.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
16.4.2 CHINA
16.4.2.1 AI diagnostic approvals to accelerate market growth
16.4.3 JAPAN
16.4.3.1 Aging demographics to drive demand for scalable imaging solutions
16.4.4 INDIA
16.4.4.1 Government-led digitization to fuel imaging infrastructure expansion
16.4.5 REST OF ASIA PACIFIC
16.5 LATIN AMERICA
16.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
16.5.2 BRAZIL
16.5.2.1 Government investments to accelerate public health digitization drives
16.5.3 MEXICO
16.5.3.1 Accelerating imaging modernization through nationwide digital integration in Mexico to boost market
16.5.4 REST OF LATIN AMERICA
16.6 MIDDLE EAST & AFRICA
16.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
16.6.2 GCC COUNTRIES
16.6.2.1 Enterprise imaging adoption accelerates across GCC amid workforce gaps and digital health push to support growth
16.6.3 REST OF MIDDLE EAST & AFRICA
17 COMPETITIVE LANDSCAPE
17.1 OVERVIEW
17.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
17.3 REVENUE ANALYSIS, 2021-2025
17.4 MARKET SHARE ANALYSIS, 2025
17.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
17.5.1 STARS
17.5.2 EMERGING LEADERS
17.5.3 PERVASIVE PLAYERS
17.5.4 PARTICIPANTS
17.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
17.5.5.1 Company footprint
17.5.5.2 Region footprint
17.5.5.3 Function footprint
17.5.5.4 Application footprint
17.5.5.5 Therapeutic footprint
17.5.5.6 Deployment footprint
17.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
17.6.1 PROGRESSIVE COMPANIES
17.6.2 RESPONSIVE COMPANIES
17.6.3 DYNAMIC COMPANIES
17.6.4 STARTING BLOCKS
17.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
17.6.5.1 Detailed list of key startups/SMEs
17.6.5.2 Competitive benchmarking of startups/SMEs
17.7 VALUATION & FINANCIAL METRICS
17.7.1 FINANCIAL METRICS
17.7.2 COMPANY VALUATION
17.8 BRAND/SOFTWARE COMPARISON
17.9 COMPETITIVE SCENARIO
17.9.1 SOLUTION LAUNCHES & ENHANCEMENT
17.9.2 DEALS
17.9.3 EXPANSIONS
17.9.4 OTHER DEVELOPMENTS
18 COMPANY PROFILES
18.1 KEY PLAYERS
18.1.1 AGFA-GEVAERT GROUP
18.1.1.1 Business overview
18.1.1.2 Solutions offered
18.1.1.3 Recent developments
18.1.1.3.1 Deals
18.1.1.4 Analyst's view
18.1.1.4.1 Key strengths
18.1.1.4.2 Strategic choices
18.1.1.4.3 Weaknesses & competitive threats
18.1.2 FUJIFILM HOLDINGS CORPORATION
18.1.2.1 Business overview
18.1.2.2 Solutions offered
18.1.2.3 Recent developments
18.1.2.3.1 Solution launches
18.1.2.3.2 Deals
18.1.2.4 Analyst's view
18.1.2.4.1 Key strengths
18.1.2.4.2 Strategic choices
18.1.2.4.3 Weaknesses & competitive threats
18.1.3 GE HEALTHCARE
18.1.3.1 Business overview
18.1.3.2 Solutions offered
18.1.3.3 Recent developments
18.1.3.3.1 Solution launches & approvals
18.1.3.3.2 Deals
18.1.3.4 Analyst's view
18.1.3.4.1 Key strengths
18.1.3.4.2 Strategic choices
18.1.3.4.3 Weaknesses & competitive threats
18.1.4 KONINKLIJKE PHILIPS N.V.
18.1.4.1 Business overview
18.1.4.2 Solutions offered
18.1.4.3 Recent developments
18.1.4.3.1 Solution launches & approvals
18.1.4.3.2 Deals
18.1.4.3.3 Expansions
18.1.4.4 Analyst's view
18.1.4.4.1 Key strengths
18.1.4.4.2 Strategic choices
18.1.4.4.3 Weaknesses & competitive threats
18.1.5 SIEMENS HEALTHINEERS AG
18.1.5.1 Business overview
18.1.5.2 Solutions offered
18.1.5.3 Recent developments
18.1.5.3.1 Solution launches
18.1.5.3.2 Deals
18.1.5.4 Analyst's view
18.1.5.4.1 Key strengths
18.1.5.4.2 Strategic choices
18.1.5.4.3 Weaknesses & competitive threats
18.1.6 SECTRA AB
18.1.6.1 Business overview
18.1.6.2 Solutions offered
18.1.6.3 Recent developments
18.1.6.3.1 Solution launches & approvals
18.1.6.3.2 Deals
18.1.6.3.3 Other developments
18.1.7 OPTUM, INC.
18.1.7.1 Business overview
18.1.7.2 Solutions offered
18.1.7.3 Recent developments
18.1.7.3.1 Deals
18.1.8 CANON MEDICAL SYSTEMS CORPORATION
18.1.8.1 Business overview
18.1.8.2 Solutions offered
18.1.8.3 Recent developments
18.1.8.3.1 Deals
18.1.9 MERATIVE
18.1.9.1 Business overview
18.1.9.2 Solutions offered
18.1.9.3 Recent developments
18.1.9.3.1 Solution launches
18.1.9.3.2 Deals
18.1.9.3.3 Expansions
18.1.10 PRO MEDICUS, LTD.
18.1.10.1 Business overview
18.1.10.2 Solutions offered
18.1.10.3 Recent developments
18.1.10.3.1 Solution launches
18.1.10.3.2 Deals
18.1.11 HYLAND
18.1.11.1 Business overview
18.1.11.2 Solutions offered
18.1.11.3 Recent developments
18.1.11.3.1 Solution launches
18.1.11.3.2 Deals
18.1.11.3.3 Expansions
18.1.12 INFINITT HEALTHCARE CO., LTD.
18.1.12.1 Business overview
18.1.12.2 Recent developments
18.1.12.2.1 Solution launches & approvals
18.1.12.2.2 Deals
18.1.13 NOVARAD
18.1.13.1 Business overview
18.1.13.2 Solutions offered
18.1.13.3 Recent developments
18.1.13.3.1 Solution launches
18.1.13.3.2 Deals
18.1.14 MACH7 TECHNOLOGIES
18.1.14.1 Business overview
18.1.14.2 Solutions offered
18.1.14.3 Recent developments
18.1.14.3.1 Solution launches
18.1.14.3.2 Deals
18.1.15 HERMES MEDICAL SOLUTIONS
18.1.15.1 Business overview
18.1.15.2 Solutions offered
18.1.15.3 Recent developments
18.1.15.3.1 Solution launches, approvals, and enhancements
18.1.15.3.2 Deals
18.1.16 KONICA MINOLTA, INC.
18.1.16.1 Business overview
18.1.16.2 Solutions offered
18.1.16.3 Recent developments
18.1.16.3.1 Solution launches & enhancements
18.1.16.3.2 Deals
18.1.16.3.3 Expansions
18.1.16.3.4 Other developments
18.1.17 BRIDGEHEAD SOFTWARE LTD.
18.1.17.1 Business overview
18.1.17.2 Solutions offered
18.1.17.3 Recent developments
18.1.17.3.1 Deals
18.1.18 SCIMAGE, INC.
18.1.18.1 Business overview
18.1.18.2 Solutions offered
18.1.18.3 Recent developments
18.1.18.3.1 Solution launches
18.1.18.3.2 Deals
18.1.19 RAMSOFT INC.
18.1.19.1 Business overview
18.1.19.2 Solutions offered
18.1.19.3 Recent developments
18.1.19.3.1 Solution launches & enhancements
18.1.19.3.2 Deals
18.1.20 DICOM SYSTEMS, INC.
18.1.20.1 Business overview
18.1.20.2 Solutions offered
18.1.20.3 Recent developments
18.1.20.3.1 Deals
18.2 OTHER PLAYERS
18.2.1 POSTDICOM B.V.
18.2.2 QAELUM
18.2.3 ADVAHEALTH SOLUTIONS
18.2.4 PAXERAHEALTH
18.2.5 RAD AI
19 RESEARCH METHODOLOGY
19.1 RESEARCH DATA
19.1.1 SECONDARY DATA
19.1.1.1 Key data from secondary sources
19.1.2 PRIMARY DATA
19.1.2.1 Key data from primary sources
19.1.2.2 Breakdown of primary sources
19.2 RESEARCH APPROACH
19.3 MARKET SIZE ESTIMATION
19.4 MARKET BREAKDOWN & DATA TRIANGULATION
19.5 MARKET SHARE ESTIMATION
19.6 STUDY ASSUMPTIONS
19.7 RESEARCH LIMITATIONS
19.7.1 METHODOLOGY-RELATED LIMITATIONS
19.7.2 SCOPE-RELATED LIMITATIONS
19.8 RISK ASSESSMENT
20 APPENDIX
20.1 DISCUSSION GUIDE
20.2 KNOWLEDGESTORE: THE SUBSCRIPTION PORTAL
20.3 CUSTOMIZATION OPTIONS
20.4 RELATED REPORTS
20.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 USD EXCHANGE RATES
TABLE 2 ENTERPRISE IMAGING IT MARKET: IMPACT ANALYSIS
TABLE 3 US: TOP 30 HEALTHCARE DATA BREACHES, 2011-2026
TABLE 4 ENTERPRISE IMAGING IT MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 5 ENTERPRISE IMAGING IT MARKET: ROLE IN ECOSYSTEM
TABLE 6 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT MARKET, BY OFFERING (2025)
TABLE 7 INDICATIVE PRICING FOR ENTERPRISE IMAGING IT SOLUTIONS, BY REGION (2025)
TABLE 8 ENTERPRISE IMAGING IT MARKET: KEY CONFERENCES & EVENTS, 2026-2027
TABLE 9 CASE STUDY 1: ENHANCING IMAGING EFFICIENCY & SECURITY WITH SECTRA’S AUTOMATED MULTIMEDIA WORKFLOW
TABLE 10 CASE STUDY 2: ENTERPRISE IMAGING CONSOLIDATION AT PIEDMONT HEALTHCARE WITH HYLAND VNA
TABLE 11 CASE STUDY 3: ENTERPRISE-WIDE IMAGING UNIFICATION WITH GE’S EDISON DATALOGUE AT A LEADING MEDICAL CENTER
TABLE 12 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 13 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR ENTERPRISE IMAGING IT MARKET
TABLE 14 ENTERPRISE IMAGING IT MARKET: LIST OF PATENTS/PATENT APPLICATIONS
TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,AND OTHER ORGANIZATIONS
TABLE 20 REGULATORY SCENARIO OF NORTH AMERICA
TABLE 21 REGULATORY SCENARIO OF EUROPE
TABLE 22 REGULATORY SCENARIO OF ASIA PACIFIC
TABLE 23 REGULATORY SCENARIO OF LATIN AMERICA
TABLE 24 REGULATORY SCENARIO OF MIDDLE EAST & AFRICA
TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OFTOP THREE END USERS (%)
TABLE 26 KEY BUYING CRITERIA FOR TOP THREE END USERS
TABLE 27 UNMET NEEDS IN ENTERPRISE IMAGING IT MARKET
TABLE 28 END USER EXPECTATIONS IN ENTERPRISE IMAGING IT MARKET
TABLE 29 ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 30 VENDOR-NEUTRAL ARCHIVES (VNA) OFFERED BY KEY MARKET PLAYERS
TABLE 31 ENTERPRISE IMAGING IT MARKET FOR VENDOR-NEUTRAL ARCHIVES (VNA),BY REGION, 2024-2031 (USD MILLION)
TABLE 32 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS) OFFEREDBY KEY MARKET PLAYERS
TABLE 33 ENTERPRISE IMAGING IT MARKET FOR PICTURE ARCHIVING AND COMMUNICATION SYSTEMS (PACS), BY REGION, 2024-2031 (USD MILLION)
TABLE 34 IMAGE EXCHANGE SOLUTIONS OFFERED BY KEY MARKET PLAYERS
TABLE 35 ENTERPRISE IMAGING IT MARKET FOR IMAGE EXCHANGE,BY REGION, 2024-2031 (USD MILLION)
TABLE 36 UNIVERSAL VIEWERS OFFERED BY KEY MARKET PLAYERS
TABLE 37 ENTERPRISE IMAGING IT MARKET FOR UNIVERSAL VIEWERS,BY REGION, 2024-2031 (USD MILLION)
TABLE 38 WORKFLOW ORCHESTRATION SOLUTIONS OFFERED BY KEY MARKET PLAYERS
TABLE 39 ENTERPRISE IMAGING IT MARKET FOR WORKFLOW ORCHESTRATION,BY REGION, 2024-2031 (USD MILLION)
TABLE 40 ANALYTICS SOLUTIONS OFFERED BY KEY MARKET PLAYERS
TABLE 41 ENTERPRISE IMAGING IT MARKET FOR ANALYTICS, BY REGION,2024-2031 (USD MILLION)
TABLE 42 ENTERPRISE IMAGING IT MARKET FOR OTHER FUNCTIONS,BY REGION, 2024-2031 (USD MILLION)
TABLE 43 ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 44 ENTERPRISE IMAGING IT MARKET FOR X-RAY, BY REGION,2024-2031 (USD MILLION)
TABLE 45 ENTERPRISE IMAGING IT MARKET FOR MRI, BY REGION,2024-2031 (USD MILLION)
TABLE 46 ENTERPRISE IMAGING IT MARKET FOR CT, BY REGION,2024-2031 (USD MILLION)
TABLE 47 ENTERPRISE IMAGING IT MARKET FOR ULTRASOUND, BY REGION,2024-2031 (USD MILLION)
TABLE 48 ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE,2024-2031 (USD MILLION)
TABLE 49 ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY REGION,2024-2031 (USD MILLION)
TABLE 50 ENTERPRISE IMAGING IT MARKET FOR PET, BY REGION,2024-2031 (USD MILLION)
TABLE 51 ENTERPRISE IMAGING IT MARKET FOR SPECT, BY REGION,2024-2031 (USD MILLION)
TABLE 52 ENTERPRISE IMAGING IT MARKET FOR ENDOSCOPY, BY REGION,2024-2031 (USD MILLION)
TABLE 53 ENTERPRISE IMAGING IT MARKET FOR MAMMOGRAPHY, BY REGION,2024-2031 (USD MILLION)
TABLE 54 ENTERPRISE IMAGING IT MARKET FOR FLUOROSCOPY, BY REGION,2024-2031 (USD MILLION)
TABLE 55 ENTERPRISE IMAGING IT MARKET FOR ECHOCARDIOGRAPHY,BY REGION, 2024-2031 (USD MILLION)
TABLE 56 ENTERPRISE IMAGING IT MARKET FOR OTHER MODALITIES,BY REGION, 2024-2031 (USD MILLION)
TABLE 57 ENTERPRISE IMAGING IT MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 58 ENTERPRISE IMAGING IT MARKET FOR DIAGNOSTIC APPLICATIONS,BY REGION, 2024-2031 (USD MILLION)
TABLE 59 ENTERPRISE IMAGING IT MARKET FOR THERAPEUTIC APPLICATIONS,BY REGION, 2024-2031 (USD MILLION)
TABLE 60 ENTERPRISE IMAGING IT MARKET FOR CLINICAL RESEARCH APPLICATIONS,BY REGION, 2024-2031 (USD MILLION)
TABLE 61 ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 62 ENTERPRISE IMAGING IT MARKET FOR SOFTWARE, BY REGION,2024-2031 (USD MILLION)
TABLE 63 ENTERPRISE IMAGING IT MARKET FOR SERVICES, BY REGION,2024-2031 (USD MILLION)
TABLE 64 ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 65 ENTERPRISE IMAGING IT MARKET FOR ON-PREMISES SOLUTIONS,BY REGION, 2024-2031 (USD MILLION)
TABLE 66 ENTERPRISE IMAGING IT MARKET FOR CLOUD-BASED SOLUTIONS,BY REGION, 2024-2031 (USD MILLION)
TABLE 67 ENTERPRISE IMAGING IT MARKET FOR HYBRID SOLUTIONS,BY REGION, 2024-2031 (USD MILLION)
TABLE 68 ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 69 ENTERPRISE IMAGING IT MARKET FOR NEUROLOGY, BY REGION,2024-2031 (USD MILLION)
TABLE 70 ENTERPRISE IMAGING IT MARKET FOR CARDIOLOGY, BY REGION,2024-2031 (USD MILLION)
TABLE 71 ENTERPRISE IMAGING IT MARKET FOR ONCOLOGY, BY REGION,2024-2031 (USD MILLION)
TABLE 72 ENTERPRISE IMAGING IT MARKET FOR ORTHOPEDICS, BY REGION,2024-2031 (USD MILLION)
TABLE 73 ENTERPRISE IMAGING IT MARKET FOR OTHER THERAPEUTIC AREAS,BY REGION, 2024-2031 (USD MILLION)
TABLE 74 ENTERPRISE IMAGING IT MARKET, FOR END USER, 2024-2031 (USD MILLION)
TABLE 75 ENTERPRISE IMAGING IT MARKET FOR HOSPITALS, BY REGION,2024-2031 (USD MILLION)
TABLE 76 ENTERPRISE IMAGING IT MARKET FOR DIAGNOSTIC CENTERS,BY REGION, 2024-2031 (USD MILLION)
TABLE 77 ENTERPRISE IMAGING IT MARKET FOR CLINICS & OUTPATIENT SETTINGS,BY REGION, 2024-2031 (USD MILLION)
TABLE 78 ENTERPRISE IMAGING IT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2031 (USD MILLION)
TABLE 79 ENTERPRISE IMAGING IT MARKET FOR MEDTECH COMPANIES,BY REGION, 2024-2031 (USD MILLION)
TABLE 80 ENTERPRISE IMAGING IT MARKET FOR RESEARCH & ACADEMIC INSTITUTES,BY REGION, 2024-2031 (USD MILLION)
TABLE 81 ENTERPRISE IMAGING IT MARKET FOR OTHER END USERS,BY REGION, 2024-2031 (USD MILLION)
TABLE 82 ENTERPRISE IMAGING IT MARKET, BY REGION, 2024-2031 (USD MILLION)
TABLE 83 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 84 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 85 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 86 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 87 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 88 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 89 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024-2031 (USD MILLION)
TABLE 90 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 91 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 92 US: KEY MACROINDICATORS
TABLE 93 US: ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 94 US: ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 95 US: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 96 US: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 97 US: ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 98 US: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 99 US: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 100 US: ENTERPRISE IMAGING IT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 101 CANADA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 102 CANADA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 103 CANADA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 104 CANADA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 105 CANADA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 106 CANADA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 107 CANADA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 108 CANADA: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 109 EUROPE: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 110 EUROPE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 111 EUROPE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 112 EUROPE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 113 EUROPE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 114 EUROPE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 115 EUROPE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 116 EUROPE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 117 EUROPE: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 118 GERMANY: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 119 GERMANY: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 120 GERMANY: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 121 GERMANY: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 122 GERMANY: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 123 GERMANY: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 124 GERMANY: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 125 GERMANY: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 126 UK: ENTERPRISE IMAGING IT MARKET, BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 127 UK: ENTERPRISE IMAGING IT MARKET, BY MODALITY, 2024-2031 (USD MILLION)
TABLE 128 UK: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 129 UK: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 130 UK: ENTERPRISE IMAGING IT MARKET, BY OFFERING, 2024-2031 (USD MILLION)
TABLE 131 UK: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 132 UK: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 133 UK: ENTERPRISE IMAGING IT MARKET, BY END USER, 2024-2031 (USD MILLION)
TABLE 135 FRANCE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 136 FRANCE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 137 FRANCE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 138 FRANCE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 139 FRANCE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 140 FRANCE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 141 FRANCE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 142 FRANCE: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 144 ITALY: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 145 ITALY: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 146 ITALY: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 147 ITALY: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 148 ITALY: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 149 ITALY: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 150 ITALY: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 151 ITALY: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 152 SPAIN: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 153 SPAIN: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 154 SPAIN: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 155 SPAIN: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 156 SPAIN: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 157 SPAIN: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 158 SPAIN: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 159 SPAIN: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 160 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 161 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 163 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 164 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 165 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 166 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024-2031 (USD MILLION)
TABLE 167 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 168 REST OF EUROPE: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 169 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 170 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 171 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 172 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 173 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 174 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 175 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 176 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 177 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 178 CHINA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 179 CHINA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 180 CHINA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 181 CHINA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 182 CHINA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 183 CHINA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 184 CHINA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 185 CHINA: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 186 JAPAN: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 187 JAPAN: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 188 JAPAN: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 189 JAPAN: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 190 JAPAN: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 191 JAPAN: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 192 JAPAN: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 193 JAPAN: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 194 INDIA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 195 INDIA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 196 INDIA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 197 INDIA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 198 INDIA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 199 INDIA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 200 INDIA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 201 INDIA: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 202 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 203 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 204 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 205 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 206 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 207 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024-2031 (USD MILLION)
TABLE 208 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 209 REST OF ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 210 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY COUNTRY,2024-2031 (USD MILLION)
TABLE 211 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 212 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 213 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 214 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 215 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 216 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024-2031 (USD MILLION)
TABLE 217 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 218 LATIN AMERICA: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 219 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 220 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 221 BRAZIL: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 222 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 223 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 224 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 225 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 226 BRAZIL: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 227 MEXICO: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 228 MEXICO: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 229 MEXICO: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 230 MEXICO: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 231 MEXICO: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 232 MEXICO: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE,2024-2031 (USD MILLION)
TABLE 233 MEXICO: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA,2024-2031 (USD MILLION)
TABLE 234 MEXICO: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 235 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 236 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,BY MODALITY, 2024-2031 (USD MILLION)
TABLE 237 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 238 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 239 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,BY OFFERING, 2024-2031 (USD MILLION)
TABLE 240 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,BY DEPLOYMENT MODE, 2024-2031 (USD MILLION)
TABLE 241 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 242 REST OF LATIN AMERICA: ENTERPRISE IMAGING IT MARKET,BY END USER, 2024-2031 (USD MILLION)
TABLE 243 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY COUNTRY, 2024-2031 (USD MILLION)
TABLE 244 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 245 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY MODALITY, 2024-2031 (USD MILLION)
TABLE 246 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 247 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 248 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY OFFERING, 2024-2031 (USD MILLION)
TABLE 249 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY DEPLOYMENT MODE, 2024-2031 (USD MILLION)
TABLE 250 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 251 MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY END USER, 2024-2031 (USD MILLION)
TABLE 252 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY FUNCTION,2024-2031 (USD MILLION)
TABLE 253 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY MODALITY,2024-2031 (USD MILLION)
TABLE 254 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING,BY TYPE, 2024-2031 (USD MILLION)
TABLE 255 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY APPLICATION,2024-2031 (USD MILLION)
TABLE 256 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY OFFERING,2024-2031 (USD MILLION)
TABLE 257 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY DEPLOYMENT MODE, 2024-2031 (USD MILLION)
TABLE 258 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 259 GCC COUNTRIES: ENTERPRISE IMAGING IT MARKET, BY END USER,2024-2031 (USD MILLION)
TABLE 260 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY FUNCTION, 2024-2031 (USD MILLION)
TABLE 261 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY MODALITY, 2024-2031 (USD MILLION)
TABLE 262 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET FOR NUCLEAR IMAGING, BY TYPE, 2024-2031 (USD MILLION)
TABLE 263 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY APPLICATION, 2024-2031 (USD MILLION)
TABLE 264 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY OFFERING, 2024-2031 (USD MILLION)
TABLE 265 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY DEPLOYMENT MODE, 2024-2031 (USD MILLION)
TABLE 266 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY THERAPEUTIC AREA, 2024-2031 (USD MILLION)
TABLE 267 REST OF MIDDLE EAST & AFRICA: ENTERPRISE IMAGING IT MARKET,BY END USER, 2024-2031 (USD MILLION)
TABLE 268 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023-2026
TABLE 269 ENTERPRISE IMAGING IT MARKET: DEGREE OF COMPETITION
TABLE 270 ENTERPRISE IMAGING IT MARKET: REGION FOOTPRINT
TABLE 271 ENTERPRISE IMAGING IT MARKET: FUNCTION FOOTPRINT
TABLE 272 ENTERPRISE IMAGING IT MARKET: APPLICATION FOOTPRINT
TABLE 273 ENTERPRISE IMAGING IT MARKET: THERAPEUTIC FOOTPRINT
TABLE 274 ENTERPRISE IMAGING IT MARKET: DEPLOYMENT FOOTPRINT
TABLE 275 ENTERPRISE IMAGING IT MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 276 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY REGION
TABLE 277 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY FUNCTION
TABLE 278 ENTERPRISE IMAGING IT MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS, BY THERAPEUTIC AREA
TABLE 279 ENTERPRISE IMAGING IT MARKET: SOLUTION LAUNCHES & ENHANCEMENT, JANUARY 2023-OCTOBER 2026
TABLE 280 ENTERPRISE IMAGING IT MARKET: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 281 ENTERPRISE IMAGING IT MARKET: EXPANSIONS, JANUARY 2023-OCTOBER 2026
TABLE 282 ENTERPRISE IMAGING IT MARKET: OTHER DEVELOPMENTS, JANUARY 2023-OCTOBER 2026
TABLE 283 AGFA-GEVAERT GROUP: COMPANY OVERVIEW
TABLE 284 AGFA-GEVAERT GROUP: SOLUTIONS OFFERED
TABLE 285 AGFA-GEVAERT GROUP: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 286 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
TABLE 287 FUJIFILM HOLDINGS CORPORATION: SOLUTIONS OFFERED
TABLE 288 FUJIFILM HOLDINGS CORPORATION: SOLUTION LAUNCHES,JANUARY 2023-OCTOBER 2026
TABLE 289 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 290 GE HEALTHCARE: COMPANY OVERVIEW
TABLE 291 GE HEALTHCARE: SOLUTIONS OFFERED
TABLE 292 GE HEALTHCARE: SOLUTION LAUNCHES & APPROVALS,JANUARY 2023-OCTOBER 2026
TABLE 293 GE HEALTHCARE: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 294 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
TABLE 295 KONINKLIJKE PHILIPS N.V.: SOLUTIONS OFFERED
TABLE 296 KONINKLIJKE PHILIPS N.V.: SOLUTION LAUNCHES & APPROVALS,JANUARY 2023-OCTOBER 2026
TABLE 297 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 298 KONINKLIJKE PHILIPS N.V.: EXPANSIONS, JANUARY 2023-OCTOBER 2026
TABLE 299 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
TABLE 300 SIEMENS HEALTHINEERS AG: SOLUTIONS OFFERED
TABLE 301 SIEMENS HEALTHINEERS AG: SOLUTION LAUNCHES,JANUARY 2023-OCTOBER 2026
TABLE 302 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 303 SECTRA AB: COMPANY OVERVIEW
TABLE 304 SECTRA AB: SOLUTIONS OFFERED
TABLE 305 SECTRA AB: SOLUTION LAUNCHES & APPROVALS, JANUARY 2023-OCTOBER 2026
TABLE 306 SECTRA AB: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 307 SECTRA AB: OTHER DEVELOPMENTS, JANUARY 2023-OCTOBER 2026
TABLE 308 OPTUM, INC.: COMPANY OVERVIEW
TABLE 309 OPTUM, INC.: SOLUTIONS OFFERED
TABLE 310 OPTUM, INC.: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 311 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
TABLE 312 CANON MEDICAL SYSTEMS CORPORATION: SOLUTIONS OFFERED
TABLE 313 CANON MEDICAL SYSTEMS CORPORATION: DEALS,JANUARY 2023-OCTOBER 2026
TABLE 314 MERATIVE: COMPANY OVERVIEW
TABLE 315 MERATIVE: SOLUTIONS OFFERED
TABLE 316 MERATIVE: SOLUTION LAUNCHES, JANUARY 2023-OCTOBER 2026
TABLE 317 MERATIVE: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 318 MERATIVE: EXPANSIONS, JANUARY 2023-OCTOBER 2026
TABLE 319 PRO MEDICUS, LTD.: COMPANY OVERVIEW
TABLE 320 PRO MEDICUS, LTD.: SOLUTIONS OFFERED
TABLE 321 PRO MEDICUS, LTD.: SOLUTION LAUNCHES, JANUARY 2023-OCTOBER 2026
TABLE 322 PRO MEDICUS, LTD.: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 323 HYLAND: COMPANY OVERVIEW
TABLE 324 HYLAND: SOLUTIONS OFFERED
TABLE 325 HYLAND: SOLUTION LAUNCHES, JANUARY 2023-OCTOBER 2026
TABLE 326 HYLAND: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 327 HYLAND: EXPANSIONS, JANUARY 2023-OCTOBER 2026
TABLE 328 INFINITT HEALTHCARE CO., LTD.: COMPANY OVERVIEW
TABLE 329 INFINITT HEALTHCARE CO., LTD.: SOLUTIONS OFFERED
TABLE 330 INFINITT HEALTHCARE CO., LTD.: SOLUTION LAUNCHES & APPROVALS,JANUARY 2023-OCTOBER 2026
TABLE 331 INFINITT HEALTHCARE CO., LTD.: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 332 NOVARAD: COMPANY OVERVIEW
TABLE 333 NOVARAD: SOLUTIONS OFFERED
TABLE 334 NOVARAD: SOLUTION LAUNCHES, JANUARY 2023-OCTOBER 2026
TABLE 335 NOVARAD: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 336 MACH7 TECHNOLOGIES: COMPANY OVERVIEW
TABLE 337 MACH7 TECHNOLOGIES: SOLUTIONS OFFERED
TABLE 338 MACH7 TECHNOLOGIES: SOLUTION LAUNCHES, JANUARY 2023-OCTOBER 2026
TABLE 339 MACH7 TECHNOLOGIES: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 340 HERMES MEDICAL SOLUTIONS: COMPANY OVERVIEW
TABLE 341 HERMES MEDICAL SOLUTIONS: SOLUTIONS OFFERED
TABLE 342 HERMES MEDICAL SOLUTIONS: SOLUTION LAUNCHES, APPROVALS,AND ENHANCEMENTS, JANUARY 2023-OCTOBER 2026
TABLE 343 HERMES MEDICAL SOLUTIONS: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 344 KONICA MINOLTA, INC.: COMPANY OVERVIEW
TABLE 345 KONICA MINOLTA, INC.: SOLUTIONS OFFERED
TABLE 346 KONICA MINOLTA, INC.: SOLUTION LAUNCHES & ENHANCEMENTS,JANUARY 2023-OCTOBER 2026
TABLE 347 KONICA MINOLTA, INC.: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 348 KONICA MINOLTA, INC.: EXPANSIONS, JANUARY 2023-OCTOBER 2026
TABLE 349 KONICA MINOLTA, INC.: OTHER DEVELOPMENTS, JANUARY 2023-OCTOBER 2026
TABLE 350 BRIDGEHEAD SOFTWARE LTD.: COMPANY OVERVIEW
TABLE 351 BRIDGEHEAD SOFTWARE LTD.: SOLUTIONS OFFERED
TABLE 352 BRIDGEHEAD SOFTWARE LTD.: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 353 SCIMAGE, INC.: COMPANY OVERVIEW
TABLE 354 SCIMAGE, INC.: SOLUTIONS OFFERED
TABLE 355 SCIMAGE, INC.: SOLUTION LAUNCHES, JANUARY 2023-OCTOBER 2026
TABLE 356 SCIMAGE, INC.: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 357 RAMSOFT INC.: COMPANY OVERVIEW
TABLE 358 RAMSOFT INC.: SOLUTIONS OFFERED
TABLE 359 RAMSOFT INC.: SOLUTION LAUNCHES & ENHANCEMENTS,JANUARY 2023-OCTOBER 2026
TABLE 360 RAMSOFT INC.: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 361 DICOM SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 362 DICOM SYSTEMS, INC.: SOLUTIONS OFFERED
TABLE 363 DICOM SYSTEMS, INC.: DEALS, JANUARY 2023-OCTOBER 2026
TABLE 364 RISK ASSESSMENT: ENTERPRISE IMAGING IT MARKET
LIST OF FIGURES
FIGURE 1 ENTERPRISE IMAGING IT MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL ENTERPRISE IMAGING IT MARKET, 2024-2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET, 2023-2026
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF ENTERPRISE IMAGING IT MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN ENTERPRISE IMAGING IT MARKET, 2026-2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN ENTERPRISE IMAGING IT MARKET DURING FORECAST PERIOD
FIGURE 8 RISING IN IMAGING VOLUMES TO DRIVE GROWTH IN ENTERPRISEIMAGING IT MARKET
FIGURE 9 DIAGNOSTICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHAREIN NORTH AMERICA IN 2025
FIGURE 10 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 11 ENTERPRISE IMAGING IT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,AND CHALLENGES
FIGURE 12 HEALTHCARE SECURITY BREACHES OF 500+ RECORDS IN US, 2009-2026
FIGURE 13 US: MEDIAN HEALTHCARE DATA BREACH SIZE BY YEAR, 2008-2028
FIGURE 14 ENTERPRISE IMAGING IT MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 15 ENTERPRISE IMAGING IT MARKET: VALUE CHAIN ANALYSIS
FIGURE 16 ENTERPRISE IMAGING IT MARKET: ECOSYSTEM ANALYSIS
FIGURE 17 REVENUE SHIFT IN ENTERPRISE IMAGING IT MARKET
FIGURE 18 RECENT FUNDING OF PLAYERS IN ENTERPRISE IMAGING IT MARKET
FIGURE 19 PATENT PUBLICATION TRENDS IN ENTERPRISE IMAGING IT MARKET, 2015-2026
FIGURE 20 JURISDICTION AND TOP APPLICANT ANALYSIS FOR ENTERPRISE IMAGINGIT MARKET
FIGURE 21 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ENTERPRISE IMAGING IT MARKET (JANUARY 2015-OCTOBER 2026)
FIGURE 22 MARKET POTENTIAL OF AI/GENERATIVE AI IN ENHANCING ENTERPRISEIMAGING IT ACROSS INDUSTRIES
FIGURE 23 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
FIGURE 25 KEY BUYING CRITERIA FOR TOP THREE END USERS
FIGURE 26 NORTH AMERICA: ENTERPRISE IMAGING IT MARKET SNAPSHOT
FIGURE 27 ASIA PACIFIC: ENTERPRISE IMAGING IT MARKET SNAPSHOT
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS IN ENTERPRISE IMAGING IT MARKET,2021-2025 (USD MILLION)
FIGURE 29 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
FIGURE 30 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31 ENTERPRISE IMAGING IT MARKET: COMPANY FOOTPRINT
FIGURE 32 ENTERPRISE IMAGING IT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33 EV/EBITDA OF KEY VENDORS
FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETAOF KEY VENDORS
FIGURE 35 ENTERPRISE IMAGING IT MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS
FIGURE 36 AGFA-GEVAERT GROUP: COMPANY SNAPSHOT (2025)
FIGURE 37 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 38 GE HEALTHCARE: COMPANY SNAPSHOT (2025)
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025)
FIGURE 40 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025)
FIGURE 41 SECTRA AB: COMPANY SNAPSHOT (2025)
FIGURE 42 OPTUM, INC.: COMPANY SNAPSHOT (2025)
FIGURE 43 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2025)
FIGURE 44 PRO MEDICUS, LTD.: COMPANY SNAPSHOT (2025)
FIGURE 45 MACH7 TECHNOLOGIES: COMPANY SNAPSHOT (2024)
FIGURE 46 KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2026)
FIGURE 47 RESEARCH DESIGN
FIGURE 48 PRIMARY SOURCES
FIGURE 49 INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 50 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,AND REGION
FIGURE 51 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 52 BOTTOM-UP APPROACH
FIGURE 53 TOP-DOWN APPROACH
FIGURE 54 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2026-2031)
FIGURE 55 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 56 DATA TRIANGULATION METHODOLOGY

Table Information

Report AttributeDetails
No. of Pages421
PublishedOctober 2026
Forecast Period2026 - 2031
Estimated Market Value ( USD ) in 2026 $ 2.58 billion
Forecasted Market Value ( USD ) by 2031 $ 4.59 billion
Compound Annual Growth Rate12.2%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Vendor Neutral Archive & PACS Market by Product Type, Modality, Application, End User - Global Forecast to 2031 - Product Image

Vendor Neutral Archive & PACS Market by Product Type, Modality, Application, End User - Global Forecast to 2031

  • Report
  • 326 Pages
  • Global
From
Medical Imaging Picture Archiving and Communication System (PACS) Market Report 2026 - Product Image

Medical Imaging Picture Archiving and Communication System (PACS) Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Vendor Neutral Archive (VNA) and PACS - Global Strategic Business Report - Product Image

Vendor Neutral Archive (VNA) and PACS - Global Strategic Business Report

  • Report
  • 486 Pages
  • Global
From
Vendor Neutral Archive & PACS Market - Global Forecast 2026-2032 - Product Image

Vendor Neutral Archive & PACS Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Picture Archiving And Communication System(PACs) Market - Global Forecast 2026-2032 - Product Image

Picture Archiving And Communication System(PACs) Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.